Publications
372
Citations
11,607
Est. group size
~3
Recurring co-author estimate
Active years
53
Publishing since 1973
Gerard J. Nuovo works in pathology-oriented cancer and virology research, with a focus on human papillomavirus (HPV) infection and its role in cancers of the skin, mouth, and cervix. His work also touches on molecular tools for detecting disease-related genetic material (such as microRNAs) in tissue samples, oncolytic virus therapy (using viruses to fight tumors), and studies of cancer types including glioma, hepatocellular carcinoma, and multiple myeloma. Much of the recent output includes detailed case reports and supplementary data files supporting laboratory and clinical studies.
Publication output has fluctuated year to year over the last decade, with a pronounced spike in 2023 followed by a marked drop in 2024-2025, suggesting an irregular rather than steadily growing or declining pace.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A Putative Role for the BCL2 Family of Proteins in the Pathophysiology of ALS
CNS & Neurological Disorders - Drug Targets · 2025
- Development of multiple human papillomavirus-16-associated digital squamous cell carcinomas and human papillomavirus-16-associated oral squamous cell carcinoma in an immunocompetent adult
JAAD Case Reports · 2024
- Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer
Nature Communications · 2023
- Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial
Clinical Cancer Research · 2023
- Focal epithelial hyperplasia associated with human papillomavirus-13 in a healthy Haitian adult
JAAD Case Reports · 2023
- Data from miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
2023
- Supplementary Table 1 from Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
2023
- Supplementary Figure 1 from Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
2023
- Supplementary Figure 5 from Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
2023
- Supplementary Figure 7 from Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
2023
- Supplementary Data from Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
2023
- Data from Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
2023
- Data from Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
2023
- Supplementary Table 1 from Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
2023
- Supplementary Figures 1-7, Tables 1-2 from miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
2023
- Annals of Diagnostic Pathology×17
- Figshare×10
- Elsevier eBooks×5
- Human Pathology×2
- Clinical Cancer Research×2
- Marsha DeSmet
Medicine · Indiana University
- Louise Ferrall
Medicine · Indiana University
- Jessica González
Medicine · Indiana University
- Melissa Randolph
Medicine · Indiana University
- Elliot J. Androphy
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile